NGAL Rapid Test poct Kits by fluorensense immunoassay analyzer

                       NGAL Rapid Test Poct Kits

Methodology                                                                                 

Fluorescence  Immunoassay

NGAL                                                                                               

1.The optimal marker for early diagnosis of acute kidney injury(AKI).

2.Independent risk index to evaluate

3.progression of chronic kidney disease(CKD)

NGAL Urine Specs                                                                      

Clinical Significance                                                                  

1.Optimal indicator for early diagnosis of acute kidney injury

2.Real-time risk stratification of acute kidney injury

3.Treatment and detection of acute kidney injury and prognosis evaluation

Performance Analysis                                                              

 Correlation analysis between Norman NGAL and Abbott NGAL

Advantage                                                                                      

High sensitivity:5ng/ml

High accuracy: 98% correlation with Abbott

Wide linear range:5-300ng/ml

Small sample size:5ul(urine)

Applicable Instruments                                                           

Fluorescence Immunoassay Analyzer

Fluorescent Immunoassays (FIA)                                       

Fluorescent Immunoassays are simply a different type of immunoassay.

The key variable is the biochemical technique used for detecting the

binding of the "detection" antibody and the analyte molecule.

The advantages of a Fluorescent detection system      

The advantages of a Fluorescent detection system have been known for many

years. These include higher sensitivity detection of the analyte, simplified 

reagents and simpler assay designs. 

Several breakthroughs have occurred over the past few years that have enabled 

the implementation of a fluorescent based immunoassay system at the point of 

care.

NGAL Kits Show                                                                          

Product Name                                                                              

Methodology:Fluorescence  immunoassay

The optimal marker for early diagnosis of acute kidney injury(AKI).

Package                                                                                           

Test card: Aluminum foil pouch 1pc/bag, desiccant

Package size: 25pcs/box

Test Method                                                                                  

Immunefluorescence techniques

Instruction for use :

Please read the manual and instrument operation 

carefully before using.Check whether the equipment can operate regularly, 

and prepare other related materials. 

Allow the test device, PCT buffer and specimen balanced to room temperature 

(15-30℃) prior to testing. 

Minimizing exposure to damp air.

Interpretation of test results                                                 

1 The analysis of test results are accomplished by immune-fluorescence quantitative 

analyzer of our company's NORMAN series.

2 The concentration of NAGAL in the  samples can be read directly in the corresponding 

batch of ID card standard curve by fluorescence signal valuewe measured. The default 

results use ng/ml as a unit.

Test Procedure                                                                            

1.Open the Immune-fluorescence quantitative analyzer.

2.Check whether the batch number of IC card and reagent box is consistent, and then 

    insert IC card into the instrument to get the curve we wanted.

3.Remove the test device from the protective pouch and place it on a flat surface. Draw 

    in 5μl of urine sample to the centrifugal tube, and dilute with 90μl of diluents. After 

    gently mix the sample, add 90μl of diluted sample into the sample well. 

    Place the test strip at room temperature for 5 minutes.

4.Insert the test card into the hole of immune-fluorescence quantitative analyzer, and 

    click start, the instrument will scan the test card automatically.

5.Immune-fluorescence quantitative analyzer detects results automatically and calculates

    the content of NGAL in the sample.

6.Specimens, used strip and transfer pipettes may be potentially infectious. Proper handling

    and disposal methods should be established by the laboratory direction in accordance

    with local regulations.

Package & Delivery                                                                    

Related Products                                                                        

About us                                                                                         

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and 

manufacturing of automated chemiluminescence system. Founded in 2008, Norman 

biological has been upholding the idea that R&D shapes future ,and concentration 

determines success. Ever since the beginning, Norman has been focusing on developing 

and manufacturing chemiluminescence instruments and reagents.

Norman's manufacture center is located in the Yuhua District and owns an over 

2,000m2 GMP-approved clean workshop. The R&D base, which is over 2,000m2 ,

 is located in state-level new Jiangbei district. Now there are over 100 R&D engineers, 

40% of which hold a PhD or master's degree.

Powered by advanced technology and excellent talents in the IVD field, Norman has been 

consistently improving its innovation platform , and increasing R&D investment. Self-

innovation, combined with long-term strategic cooperation with universities and research

institutes and with outsourced technologies, ensures consistent improvement on product 

quality. 

Norman's R&D field has covered instruments, reagents, and raw materials, and has been 

entrusted by the Nanjing government to build a R&D center specialized in biological 

chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.

Being an expert in automated chemiluminescence analysis , Norman owns independent 

and completed intellectual property rights, and its products providetop-notch sensitivity, 

precision and accuracy . Thanks to the self-developed antigens and self-manufactured 

antibodies, Norman's products features minimized intra-and inter- batch difference.

R&D shapes future, and concentration determines success. Driven by the commitment 

to "provide complete solution to improve human health.Norman will consistently do its 

utmost to drive the IVD industry forward and contribute more to human health.

Agent Wanted                                                                              

If you are interested in working with us, please feel free to contact. 

                      OEM will be highly welcome!

                          Welcome to our website!